A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011
Clinical trial NCT07295496 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07295496
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2026-06-07
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.